Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 4552

Max Ratio

Dividend Yield

4.18 %

5Y Dividend Growth

150.00 %

Consecutive Years

5Y Average Payout Ratio

64.29 %

Dividend History 4552

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 4.18 %
Consecutive Years 0
Forward Annual Dividend 30.00 JPY
Consistent Years 3
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y 20.11 %
Payout Ratio TTM 126.78 %
Dividend CAGR 10Y 15.77 %
Ex Dividend Date 09/29/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 4552

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 4552

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 4552

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 4552

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 4552

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

JCR Pharmaceuticals Co Ltd 4552

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 4552

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE 23.26
Enterprise Value Revenue 2.97
Price Sales TTM 2.32
Enterprise Value EBITDA 1 144.80
Price Book MRQ 1.82

JCR Pharmaceuticals Co Ltd Dividends: 2.79 % Yield, History, Payment Schedule

4552
Current price
717.00 JPY +13.02 JPY (+1.85%)
Last closed 706.00 JPY
ISIN JP3701000006
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Tokyo Stock Exchange
Capitalization 77 532 914 784 JPY
Yield for 12 month -0.42 %
1Y
3Y
5Y
10Y
15Y
4552
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+33 091 489 373 JPY

Last Year

+42 896 263 945 JPY

Current Quarter

+8 574 049 783 JPY

Last Quarter

+7 196 238 224 JPY

Current Year

+21 560 698 293 JPY

Last Year

+31 269 416 263 JPY

Current Quarter

+6 177 638 406 JPY

Last Quarter

+2 819 660 644 JPY
EBITDA -535 315 252 JPY
Operating Margin TTM 23.04 %
Price to Earnings
Return On Assets TTM -2.17 %
PEG Ratio
Return On Equity TTM -4.37 %
Wall Street Target Price 100 096.23 JPY
Revenue TTM 37 799 260 452 JPY
Book Value 394.97 JPY
Revenue Per Share TTM
Dividend Share 20.01 JPY
Quarterly Revenue Growth YOY 50.30 %
Dividend Yield 4.18 %
Gross Profit TTM 26 466 586 916 JPY
Earnings per share -18.86 JPY
Diluted Eps TTM -18.86 JPY
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -87.50 %
Profit Margin -6.24 %

Technical Indicators 4552

For 52 Weeks

380.20 JPY 824.49 JPY
50 Day MA 629.81 JPY
Shares Short Prior Month
200 Day MA 559.79 JPY
Short Ratio
Shares Short
Short Percent